Equels Thomas K's Form 4 filing
AIM ImmunoTech Inc. (AIM) · filed Sep 17, 2026
- Accession no.
- 0001493152-26-043073
- Filed
- Sep 17, 2026, 12:01 PM ET
- Trade date
- Sep 16, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $2.31K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Equels Thomas KCIK 0001450324 | Director, Officer (CEO & President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Common Stock | PPurchaseAcquired | +11,000 | $0.21 | +$2,310 | 102,822 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.